Quantcast

Latest Artificial pancreas Stories

8237c2395201e0d8063d204c97e0f22d1
2010-10-28 14:19:46

Anne M Stark, Lawrence Livermore National Laboratory Beta cells, which make insulin in the human body, do not replicate after the age of 30, indicating that clinicians may be closer to better treating diabetes. Type 1 diabetes is caused by a loss of beta cells by auto-immunity while type 2 is due to a relative insufficiency of beta cells. Whether beta cells replicate after birth has remained an open issue, and is critically important for designing therapies for diabetes. By using radioactive...

2010-09-23 08:23:00

DANBURY, Conn., Sept. 23 /PRNewswire/ -- Biodel Inc. (Nasdaq: BIOD) today reported recent findings from the company's diabetes drug research program during a poster session on short-acting insulins at the 46th annual meeting of the European Association for the Study of Diabetes in Stockholm. In the first poster presentation, "Biocompatibility of the ultra-rapid insulin VIAject® (Linjeta(TM)) with continuous insulin infusion sets," Dr. Frank Flacke of Biodel reported that...

2010-07-12 06:00:00

DANBURY, Conn., July 12 /PRNewswire-FirstCall/ -- Biodel Inc. (Nasdaq: BIOD) announced today the award of two research grants by the Juvenile Diabetes Research Foundation (www.jdrf.org) to Stanford University and Oregon Health & Science University (OHSU) to evaluate the use of VIAject® (ultra-rapid-acting injectable human insulin) in the treatment of diabetes. The first grant will support clinical testing under the direction of Bruce Buckingham, M.D., professor of...

2010-06-30 12:43:07

Adding a continuous blood sugar level sensor to an insulin pump helps patients with type 1 diabetes achieve better blood sugar control compared to the common standard of care, multiple daily insulin injections, concludes a study published online June 29 in the New England Journal of Medicine. The paper is entitled, Effectiveness of Sensor-Augmented Insulin-Pump therapy in Type 1 Diabetes. "Combining the best technologies for insulin delivery and blood sugar monitoring really pays off for...

6872b1e4fb59f967901e4fe5f7c9a4371
2010-06-29 10:42:26

No immune suppression drugs needed In a step toward curing diabetes in humans, scientists at Washington University School of Medicine in St. Louis have alleviated the disease in rats using transplants from both embryonic and adult pigs. The rats adopted the pig transplants as their own and produced enough insulin to control their blood sugar "“ all without the need for anti-rejection drugs. The researchers report their findings online in the American Journal of Pathology. Using a...

2010-06-26 09:00:00

ORLANDO, Fla., June 26, 2010 /PRNewswire-FirstCall/ -- Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN) today announced results from an analysis of an integrated database of clinical studies that showed no increased risk of cardiovascular (CV) events associated with SYMLIN® (pramlintide acetate) injection use compared to a pooled comparator group treated with either placebo or rapid-acting insulin. These findings were presented at the 70th Annual Scientific Sessions of the...

2010-06-25 09:00:00

SANTA BARBARA, Calif., June 25 /PRNewswire/ -- The University of California Santa Barbara (UCSB) and Sansum Diabetes Research Institute (Sansum) announced today the achievement of a milestone in the Artificial Pancreas Project funded by the Juvenile Diabetes Research Foundation (JDRF). The world's most flexible artificial pancreas system platform, currently being used in clinical trials around the globe, now has the benefit of compatibility with Animas Corporation insulin delivery...

2010-06-24 05:23:00

DALLAS, Texas, June 24, 2010 /PRNewswire/ -- ReportsandReports announces it will carry the Diabetes Care Devices Market in Brazil, Russia, India, and China (BRIC) (2010 - 2014) Market Research Report in its store. Browse the complete Report on: http://www.reportsandreports.com/market-reports/diabetes-care-devices-mar ket-in-brazil-russia-india-and-china-/ (Due to the length of this URL, it may be necessary to copy and paste this hyperlink into your Internet browser's URL...

2010-06-18 05:58:00

LONDON, June 18, 2010 /PRNewswire/ -- An article recently published in The Lancet reports that using an artificial pancreas system overnight can significantly reduce the risk of nocturnal hypoglycemia in children and adolescents with type 1 diabetes.(1) Moreover, the first clinical trial of an artificial pancreas system delivering both insulin and glucagon has shown that this system can prevent development of hypoglycemia.(2) The latest issue of the journal Diabetic Hypoglycemia...

2010-06-16 15:49:00

JDRF Volunteer, Philanthropist, Former Internet Executive to Lead Top Funder of Cures and Treatments for People with Type 1 Diabetes and Its Complications NEW YORK, June 16 /PRNewswire-USNewswire/ -- The Juvenile Diabetes Research Foundation, a leader in type 1 diabetes research worldwide, announced today that Jeffrey Brewer has been named President and Chief Executive Officer. Mr. Brewer, an entrepreneur and philanthropist, has been a passionate JDRF volunteer and donor for the past...


Word of the Day
bodacious
  • Remarkable; prodigious.
  • Audacious; gutsy.
  • Completely; extremely.
  • Audaciously; boldly.
  • Impressively great in size; enormous; extraordinary.
This word is probably from the dialectal 'boldacious,' a blend of 'bold' and 'audacious.'
Related